Novel anticancer activity and anticancer mechanisms of Brassica oleracea L. var. capitata f. rubra

European Journal of Integrative Medicine

Volumn 5, Issue 5, 2013, Pages 450-464

  Hafidh, R R ^a,b   Abdulamir, A S ^b,c   Abu Bakar, F ^b   Jalilian, F A ^d   Jahanshiri, F ^b   Abas, F ^b   Sekawi, Z ^b  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c AL NAHRAIN UNIVERSITY   (Iraq)

^d ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticancer; Anticancer cytokines; Apoptosis; Brassica oleracea; Cell cycle arrest

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BETA INTERFERON; CASPASE 7; CASPASE 8; CASPASE 9; CYCLIN A; CYCLIN D; CYCLIN E; CYTOKINE; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; RED CABBAGE EXTRACT; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL FUNCTION; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG SELECTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RED CABBAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; UTERINE CERVIX CANCER;

EID: 84887154678     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2013.06.004     Document Type: Article

References (59)

1. Kaur M., Agarwal C., Agarwal R. Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. Journal of Nutrition 2009, 139:1806S-1812S.
2. Resistance to Anticancer Drugs-1. http://www.suite101.com/article.cfm/new_cancer_treatments/76290.
3. Chigurupati N., Saiki L., Gayser C., Dash A.K. Evaluation of red cabbage dye as a potential natural color for pharmaceutical use. International Journal of Pharmaceutics 2002, 241:293-299.
4. Arapitsas P., Turner C. Pressurized solvent extraction and monolithic column-HPLC/DAD analysis of anthocyanins in red cabbage. Talanta 2008, 74:1218-1223.
5. Hassimotto N.M., Genovese M.I., Lajolo F.M. Antioxidant activity of dietary fruits, vegetables, and commercial frozen fruit pulps. Journal of Agricultural and Food Chemistry 2005, 53(8):2928-2935.
6. Lee K.-J., Sok D.-E., Kim Y.-B., Kim M.R. Protective effect of vegetable extracts on stress in brain of mice administered with NMDA Food Research International. Food Research International 2002, 35(1):55-63.
7. Igarashi K., Kimura Y., Takenaka A. Preventive effects of dietary cabbage acylated anthocyanins on paraquat-induced oxidative stress in rats. Bioscience, Biotechnology, and Biochemistry 2000, 64(8):1600-1607.
8. Park Y.J., Jeon K.H., Kim S.H., Bae S.J. The effect on antimicrobial and cytotoxicity of Brassica oleracea L. Fractions. Journal of Life Sciences 2004, 14(4):567-572.
9. Kassie F., Uhl M., Rabot S., Grasl-Kraupp B., Verkerk R., Kundi M., et al. Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis 2003, 24(2):255-261.
10. Steinkellner H., Rabot S., Freywald C., Nobis E., Scharf G., Chabicovsky M., et al. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutation Research 2001, 480-481:285-297.
11. Lin J.Y., Lia C.Y., Hwang I.F. Characterisation of the pigment components in red cabbage (Brassica oleracea L. var.) juice and their anti-inflammatory effects on LPS-stimulated murine splenocytes. Food Chemistry 2008, 109(4):771-781.
12. Kataya H.A., Hamza A.A. Red cabbage (Brassica oleracea) ameliorates diabetic nephropathy in rats. Evidence-Based Complementary and Alternative Medicine 2008, 5(3):281-287.
13. Stratil P., Klejdus B., Kuban V. Determination of total content of phenolic compounds and their antioxidant activity in vegetables - evaluation of spectrophotometric methods. Journal of Agricultural and Food Chemistry 2006, 54(3):607-616.
14. Piazza G.A., Rahm A.L., Krutzsch M., Sperl G., Paranka N.S., Gross P.H., et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Research 1995, 55(14):3110-3116.
15. Sriwanthana B., Chavalittumrong P. In vitro effect of Derris scandens on normal lymphocyte proliferation and its activities on natural killer cells in normals and HIV-1 infected patients. Journal of Ethnopharmacology 2001, 76(1):125-129.
16. Mena-Rejon G., Caamal-Fuentes E., Cantillo-Ciau Z., Cedillo-Rivera R., Flores-Guido J., Moo-Puc R. In vitro cytotoxic activity of nine plants used in Mayan traditional medicine. Journal of Ethnopharmacology 2009, 121(3):462-465.
17. Lin C.C., Ng L.T., Hsu F.F., Shieh D.E., Chiang L.C. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icarin) on hepatoma and leukaemia cell growth. Clinical and Experimental Pharmacology and Physiology 2004, 31:65-69.
18. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 2009, 55(4):611-622.
19. Marzo I., Naval J. Bcl-2 family members as molecular targets in cancer therapy. Biochemical Pharmacology 2008, 76(8):939-946.
20. Wild C.P., Montesano R. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Letters 2009, 286(1):22-28.
21. Liu A.M., Poon R.T., Luk J.M. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochemical and Biophysical Research Communications 2010, 394(3):623-627.
22. Bolhassani A., Zahedifard F., Taslimi Y., Taghikhani M., Nahavandian B., Rafati S. Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients. Indian Journal of Medical Research 2009, 130(5):533-541.
23. Bhatla N., Moda N. The clinical utility of HPV DNA testing in cervical cancer screening strategies. Indian Journal of Medical Research 2009, 130(3):261-265.
24. Vonthron-Senecheau C., Weniger B., Ouattara M., Bi F.T., Kamenan A., Lobstein A., et al. In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants. Journal of Ethnopharmacology 2003, 87(2-3):221-225.
25. Walters D.G., Young P.J., Agus C., Knize M.G., Boobis A.R., Gooderham N.J., et al. Cruciferous vegetable consumption alters the metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans. Carcinogenesis 2004, 25(9):1659-1669.
26. Uhl M., Kassie F., Rabot S., Grasl-Kraupp B., Chakraborty A., Laky B., et al. Effect of common Brassica vegetables (Brussels sprouts and red cabbage) on the development of preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in liver and colon of Fischer 344 rats. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2004, 802(1):225-230.
27. Harborne J.B., Williams C.A. Advances in flavonoid research since 1992. Phytochemistry 2000, 55(6):481-504.
28. Rose P., Ong C.N., Whiteman M. Protective effects of Asian green vegetables against oxidant induced cytotoxicity. World Journal of Gastroenterology 2005, 11(48):7607-7614.
29. Persson C., Sasazuki S., Inoue M., Kurahashi N., Iwasaki M., Miura T., et al. Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study. Carcinogenesis 2008, 29(5):1042-1048.
30. Tseng T.H., Lee Y.J. Evaluation of natural and synthetic compounds from East Asiatic folk medicinal plants on the mediation of cancer. Anti-Cancer Agents in Medicinal Chemistry 2006, 6(4):347-365.
31. Zhou J.R., Yu L., Zhong Y., Blackburn G.L. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. Journal of Nutrition 2003, 133(2):516-521.
32. Hagiwara A., Yoshino H., Ichihara T., Kawabe M., Tamano S., Aoki H., et al. Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine. Journal of Toxicological Sciences 2002, 27(1):57-68.
33. Hou D.X., Kai K., Li J.J., Lin S., Terahara N., Wakamatsu M., et al. Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. Carcinogenesis 2004, 25(1):29-36.
34. Barbara P., Grażyna H.-C., Emilia M., Sylwester C. Stability and antioxidative properties of acylated anthocyanins in three cultivars of red cabbage (Brassica oleracea L. var. capitata L. f. rubra). Journal of the Science of Food and Agriculture 2009, 89(7):1154-1158.
35. Steinmetz K.A., Potter J.D. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes and Control 1991, 2(6):427-442.
36. Wang L.S., Stoner G.D. Anthocyanins and their role in cancer prevention. Cancer Letters 2008, 269(2):281-290.
37. Kang J.X., Liu J., Wang J., He C., Li F.P. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells. Carcinogenesis 2005, 26(11):1934-1939.
38. Tanabe S., Kinuta Y., Yasumatsu H., Takayanagi M., Kobayashi S., Takido N., et al. Effects of Citrus unshiu powder on the cytokine balance in peripheral blood mononuclear cells of patients with seasonal allergic rhinitis to pollen. Bioscience, Biotechnology, and Biochemistry 2007, 71(11):2852-2855.
39. Bertazza L., Mocellin S. Tumor necrosis factor (TNF) biology and cell death. Frontiers in Bioscience 2008, 13:2736-2743.
40. Kummalue T., Oc P., Jiratchariyakul W., Chanchai M., Pattanapanyasat K., Sukapirom K., et al. Antiproliferative effect of Erycibe elliptilimba on human breast cancer cell lines. Journal of Ethnopharmacology 2007, 110(3):439-443.
41. Swanton C. Cell-cycle targeted therapies. Lancet Oncology 2004, 5(1):27-36.
42. Kandaswami C., Lee L.T., Lee P.P., Hwang J.J., Ke F.C., Huang Y.T., et al. The antitumor activities of flavonoids. In Vivo 2005, 19(5):895-909.
43. Tsuda H., Ohshima Y., Nomoto H., Fujita K., Matsuda E., Iigo M., et al. Cancer prevention by natural compounds. Drug Metabolism and Pharmacokinetics 2004, 19(4):245-263.
44. Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis - the p53 network. Journal of Cell Science 2003, 116(Pt 20):4077-4085.
45. Erhardt P Apoptosis 2009, Humana Press, New York, NY.
46. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281(5381):1309-1312.
47. Saito M., Korsmeyer S.J., Schlesinger P.H. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nature Cell Biology 2000, 2(8):553-555.
48. Paris C., Bertoglio J., Breard J. Lysosomal and mitochondrial pathways in miltefosine-induced apoptosis in U937 cells. Apoptosis 2007, 12(7):1257-1267.
49. Chang J., Hsu Y., Kuo P., Kuo Y., Chiang L., Lin C. Increase of Bax/Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sciences 2005, 76(16):1883-1893.
50. Rao R.V., Hermel E., Castro-Obregon S., del Rio G., Ellerby L.M., Ellerby H.M., et al. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. Journal of Biological Chemistry 2001, 276(36):33869-33874.
51. Pan M.H., Chen W.J., Lin-Shiau S.Y., Ho C.T., Lin J.K. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 2002, 23(10):1677-1684.
52. Sherr C.J. Cancer cell cycles. Science 1996, 274(5293):1672-1677.
53. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Development 1995, 9(10):1149-1163.
54. Aprelikova O., Xiong Y., Liu E.T. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. Journal of Biological Chemistry 1995, 270(31):18195-18197.
55. el-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Research 1994, 54(5):1169-1174.
56. Lee J., Kim S.S. The function of p27 KIP1 during tumor development. Experimental & Molecular Medicine 2009, 41(11):765-771.
57. Moneo V., del Valle Guijarro M., Link W., Carnero A. Overexpression of cyclin D1 inhibits TNF-induced growth arrest. Journal of Cellular Biochemistry 2003, 89(3):484-499.
58. Jaruga-Killeen E., Rayford W. TNF receptor 1 is involved in the induction of apoptosis by the cyclin dependent kinase inhibitor p27Kip1 in the prostate cancer cell line PC-3. FASEB Journal 2005, 19(1):139-141.
59. Kishore R., Qin G., Luedemann C., Bord E., Hanley A., Silver M., et al. The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. Journal of Clinical Investigation 2005, 115(7):1785-1796.